NCT02571374

Symbiotics to Prevent Postoperative Infection in Colorectal Cancer

Change in Incidence of Surgical Site Infection After Resection of Colorectal Cancer Between Patients Receiving a Symbiotic Compound and Patients Receiving a Placebo.

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 92 (estimated)
• Sponsor: Hospital de Clinicas de Porto Alegre · Academic / Other
• Sex: All
• Age: 18 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

This is a double blind randomized trial in which patients with colorectal cancer undergoing surgery will be selected to receive either a symbiotic formulation or placebo. The researchers will compare incidence of surgical site infection between the study groups.

Detailed description

This is a double blind randomized trial in which patients with colorectal cancer undergoing surgery will be randomly selected to receive either a symbiotic formulation or placebo during the perioperative period. The researchers will compare incidence of surgical site infection, detected by clinical examination and complementary tests (CT scans, X-rays, microbiological and hematological tests) between the study groups.

Conditions

• Colorectal Cancer
• Surgical Site Infection

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	symbiotic group	this group received sachets of symbiotic
DIETARY_SUPPLEMENT	placebo group	this group received placebo

Timeline

• Start date: 2013-10-01
• Primary completion: 2015-12-01
• Completion: 2016-12-01
• First posted: 2015-10-08
• Last updated: 2015-10-08

Locations

1 site across 1 country: Brazil